Executive Summary
Business Insights have teamed up with IMS Health to bring you, ’The Antivirals Market Outlook: Market analysis of future growth and leading players by sector.’ This unique product offering provides an analysis of changing market conditions and strategic future outlook using the gold standard IMS Health sales data, an unrivalled source of pharmaceutical intelligence on the Antivirals market. ’The Antivirals Market Outlook: Market analysis of future growth and leading players by sector’, analyzes the market development in the US and the five major European markets. The major therapy areas covered in this report are: HIV, hepatitis, herpes, influenza, RSV and HPV. For each market therapy area there is a country-by-country analysis, a review of leading companies and an analysis of key brands allowing you to assess the best pipeline areas to invest in. Identify unmet needs and growth opportunities in each market by reviewing pipeline drugs with the most potential for profit for your company.
Other selected research from the 'Markets' category:
Indias Growth Prospects in Pharma: Evolution, Not Revolution
Recombinant Therapeutic Proteins: Delivering a $53 Billion Mature Market by 2010
Other selected research from the 'Infectious diseases' category:
Hepatitis C Market Forecast 2009
Stakeholder Opinions: Tropical Diseases - Dengue, Japanese encephalitis and West Nile virus - Increasing attention for neglected diseases
Other selected research from the 'Markets' category:
India: Pharmaceutical and biotechnology opportunities
- Who are the key players in the Indian pharmaceutical market?
- How has the Indian regulatory environment changed?
- What R&D collaborative opportunities are available?
- How can companies engage with India for collaboration?
- What are the leading R&D companies in India doing in collaborative R&D?
Reformulation Strategies - Comparisons of Past and Future Reformulation Strategies